Vaxcyte, Inc. Insider Trading for January 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Vaxcyte, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Vaxcyte, Inc. for January 2021.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 28 2021 | PCVX | Vaxcyte, Inc. | Fairman Jeff | VP, Research | Option Exercise | M | 0.04 | 4,750 | 190 | 16,759 | |
| Jan 28 2021 | PCVX | Vaxcyte, Inc. | Fairman Jeff | VP, Research | Sell | S | 25.94 | 425 | 11,025 | 1,408 | 1.8 K to 1.4 K (-23.19 %) |
| Jan 28 2021 | PCVX | Vaxcyte, Inc. | Fairman Jeff | VP, Research | Sell | S | 25.20 | 4,325 | 108,990 | 1,833 | 6.2 K to 1.8 K (-70.23 %) |
| Jan 28 2021 | PCVX | Vaxcyte, Inc. | Fairman Jeff | VP, Research | Buy | M | 0.04 | 4,750 | 190 | 6,158 | 1.4 K to 6.2 K (+337.36 %) |
| Jan 27 2021 | PCVX | Vaxcyte, Inc. | Hopfner Robert Lorne | Director | Sell | S | 25.30 | 2,140 | 54,142 | 1,803,118 | 1.8 M to 1.8 M (-0.12 %) |
| Jan 27 2021 | PCVX | Vaxcyte, Inc. | Hopfner Robert Lorne | Director | Sell | S | 26.13 | 1,373 | 35,876 | 1,805,258 | 1.8 M to 1.8 M (-0.08 %) |
| Jan 27 2021 | PCVX | Vaxcyte, Inc. | Hopfner Robert Lorne | Director | Sell | S | 25.23 | 16,769 | 423,082 | 1,806,631 | 1.8 M to 1.8 M (-0.92 %) |
| Jan 27 2021 | PCVX | Vaxcyte, Inc. | Hopfner Robert Lorne | Director | Sell | S | 26.07 | 15,461 | 403,068 | 1,823,400 | 1.8 M to 1.8 M (-0.84 %) |
| Jan 27 2021 | PCVX | Vaxcyte, Inc. | Hopfner Robert Lorne | Director | Sell | S | 25.61 | 19,511 | 499,677 | 1,838,861 | 1.9 M to 1.8 M (-1.05 %) |
| Jan 21 2021 | PCVX | Vaxcyte, Inc. | Wassil Jim | Chief Operating Off ... | Option Exercise | M | 2.42 | 3,000 | 7,260 | 248,926 | |
| Jan 21 2021 | PCVX | Vaxcyte, Inc. | Wassil Jim | Chief Operating Off ... | Sell | S | 25.50 | 3,000 | 76,500 | 16,381 | 19.4 K to 16.4 K (-15.48 %) |
| Jan 21 2021 | PCVX | Vaxcyte, Inc. | Wassil Jim | Chief Operating Off ... | Buy | M | 2.42 | 3,000 | 7,260 | 19,381 | 16.4 K to 19.4 K (+18.31 %) |
| Jan 21 2021 | PCVX | Vaxcyte, Inc. | PICKERING GRANT | President & CEO | Option Exercise | M | 1.79 | 15,000 | 26,850 | 478,815 | |
| Jan 21 2021 | PCVX | Vaxcyte, Inc. | PICKERING GRANT | President & CEO | Sell | S | 25.87 | 1,567 | 40,538 | 578,691 | 580.3 K to 578.7 K (-0.27 %) |
| Jan 21 2021 | PCVX | Vaxcyte, Inc. | PICKERING GRANT | President & CEO | Sell | S | 25.01 | 13,433 | 335,959 | 580,258 | 593.7 K to 580.3 K (-2.26 %) |
| Jan 21 2021 | PCVX | Vaxcyte, Inc. | PICKERING GRANT | President & CEO | Buy | M | 1.79 | 15,000 | 26,850 | 593,691 | 578.7 K to 593.7 K (+2.59 %) |
| Jan 19 2021 | PCVX | Vaxcyte, Inc. | Hopfner Robert Lorne | Director | Sell | S | 26.05 | 7,000 | 182,350 | 1,888,901 | 1.9 M to 1.9 M (-0.37 %) |
| Jan 19 2021 | PCVX | Vaxcyte, Inc. | Hopfner Robert Lorne | Director | Sell | S | 25.55 | 42,516 | 1,086,284 | 1,895,901 | 1.9 M to 1.9 M (-2.19 %) |
| Jan 19 2021 | PCVX | Vaxcyte, Inc. | Hopfner Robert Lorne | Director | Sell | S | 26.05 | 3,808 | 99,198 | 1,938,417 | 1.9 M to 1.9 M (-0.20 %) |
| Jan 19 2021 | PCVX | Vaxcyte, Inc. | Hopfner Robert Lorne | Director | Sell | S | 25.74 | 22,869 | 588,648 | 1,942,225 | 2 M to 1.9 M (-1.16 %) |
| Jan 19 2021 | PCVX | Vaxcyte, Inc. | Hopfner Robert Lorne | Director | Sell | S | 25.88 | 14,918 | 386,078 | 1,965,094 | 2 M to 2 M (-0.75 %) |
| Jan 19 2021 | PCVX | Vaxcyte, Inc. | Wright-Mitchell Jane | General Counsel | Option Exercise | M | 2.03 | 2,500 | 5,075 | 204,968 | |
| Jan 19 2021 | PCVX | Vaxcyte, Inc. | Wright-Mitchell Jane | General Counsel | Sell | S | 26.00 | 2,500 | 65,000 | 1,562 | 4.1 K to 1.6 K (-61.55 %) |
| Jan 19 2021 | PCVX | Vaxcyte, Inc. | Wright-Mitchell Jane | General Counsel | Buy | M | 2.03 | 2,500 | 5,075 | 4,062 | 1.6 K to 4.1 K (+160.05 %) |
| Jan 13 2021 | PCVX | Vaxcyte, Inc. | Hopfner Robert Lorne | Director | Sell | S | 26.34 | 3,100 | 81,654 | 1,980,012 | 2 M to 2 M (-0.16 %) |
| Jan 13 2021 | PCVX | Vaxcyte, Inc. | Hopfner Robert Lorne | Director | Sell | S | 25.90 | 26,010 | 673,659 | 1,983,112 | 2 M to 2 M (-1.29 %) |
| Jan 13 2021 | PCVX | Vaxcyte, Inc. | Hopfner Robert Lorne | Director | Sell | S | 27.05 | 901 | 24,372 | 2,009,122 | 2 M to 2 M (-0.04 %) |
| Jan 13 2021 | PCVX | Vaxcyte, Inc. | Hopfner Robert Lorne | Director | Sell | S | 26.35 | 17,666 | 465,499 | 2,010,023 | 2 M to 2 M (-0.87 %) |
| Jan 13 2021 | PCVX | Vaxcyte, Inc. | Hopfner Robert Lorne | Director | Sell | S | 27.02 | 12,206 | 329,806 | 2,027,689 | 2 M to 2 M (-0.60 %) |
| Jan 13 2021 | PCVX | Vaxcyte, Inc. | Hopfner Robert Lorne | Director | Sell | S | 26.69 | 24,980 | 666,716 | 2,039,895 | 2.1 M to 2 M (-1.21 %) |
| Jan 13 2021 | PCVX | Vaxcyte, Inc. | Hopfner Robert Lorne | Director | Sell | S | 25.42 | 12,480 | 317,242 | 2,064,875 | 2.1 M to 2.1 M (-0.60 %) |
| Jan 12 2021 | PCVX | Vaxcyte, Inc. | Sauer Paul | SVP Process Dev, Ma ... | Option Exercise | M | 1.79 | 2,500 | 4,475 | 26,426 | |
| Jan 12 2021 | PCVX | Vaxcyte, Inc. | Sauer Paul | SVP Process Dev, Ma ... | Sell | S | 26.74 | 1,527 | 40,832 | 77,899 | 79.4 K to 77.9 K (-1.92 %) |
| Jan 12 2021 | PCVX | Vaxcyte, Inc. | Sauer Paul | SVP Process Dev, Ma ... | Sell | S | 25.38 | 973 | 24,695 | 79,426 | 80.4 K to 79.4 K (-1.21 %) |
| Jan 12 2021 | PCVX | Vaxcyte, Inc. | Sauer Paul | SVP Process Dev, Ma ... | Buy | M | 1.79 | 2,500 | 4,475 | 80,399 | 77.9 K to 80.4 K (+3.21 %) |
| Jan 08 2021 | PCVX | Vaxcyte, Inc. | Hopfner Robert Lorne | Director | Sell | S | 28.23 | 200 | 5,646 | 2,077,355 | 2.1 M to 2.1 M (-0.01 %) |
| Jan 08 2021 | PCVX | Vaxcyte, Inc. | Hopfner Robert Lorne | Director | Sell | S | 27.08 | 8,944 | 242,204 | 2,077,555 | 2.1 M to 2.1 M (-0.43 %) |
| Jan 08 2021 | PCVX | Vaxcyte, Inc. | Hopfner Robert Lorne | Director | Sell | S | 26.43 | 31,468 | 831,699 | 2,086,499 | 2.1 M to 2.1 M (-1.49 %) |
| Jan 08 2021 | PCVX | Vaxcyte, Inc. | Hopfner Robert Lorne | Director | Sell | S | 29.51 | 469 | 13,840 | 2,117,967 | 2.1 M to 2.1 M (-0.02 %) |
| Jan 08 2021 | PCVX | Vaxcyte, Inc. | Hopfner Robert Lorne | Director | Sell | S | 28.80 | 22,587 | 650,506 | 2,118,436 | 2.1 M to 2.1 M (-1.05 %) |
| Jan 08 2021 | PCVX | Vaxcyte, Inc. | Hopfner Robert Lorne | Director | Sell | S | 27.75 | 24,524 | 680,541 | 2,141,023 | 2.2 M to 2.1 M (-1.13 %) |
| Jan 08 2021 | PCVX | Vaxcyte, Inc. | Hopfner Robert Lorne | Director | Sell | S | 29.99 | 22,507 | 674,985 | 2,165,547 | 2.2 M to 2.2 M (-1.03 %) |
| Jan 08 2021 | PCVX | Vaxcyte, Inc. | Hopfner Robert Lorne | Director | Sell | S | 29.24 | 34,913 | 1,020,856 | 2,188,054 | 2.2 M to 2.2 M (-1.57 %) |